Paragon 28, Inc., a leading orthopedic foot and ankle company, today announced the completion of a Series B financing. The round was co-led by Piper Sandler Merchant Banking, a commercial stage growth equity investment business of Piper Sandler Companies, and MVM Partners, a healthcare growth equity investment firm. The financing also included participation from an existing Series A investor. Read the full article here.
LINKS
CALL US
The name “Paragon 28” was chosen by design — to never lose focus on our goal to advance the science of foot and ankle surgery.
© 2024 Paragon 28, Inc.